NR565/ NR 565 Advanced Pharmacology
Fundamentals Midterm Exam Newest 2026 Actual
Questions and Correct Answers (Latest
Update) Graded A+ 100% Guarantee Verified by
Experts - Chamberlain
1. Which of the following best defines pharmacokinetics?
A) The effect of the drug on the body
B) The movement of the drug through the body
C) The interaction between drugs and receptors
D) The therapeutic effect produced by the drug
Correct Answer: B
Rationale: Pharmacokinetics describes the movement of a drug through the body over time,
specifically focusing on the four stages: absorption, distribution, metabolism, and excretion
(ADME). Pharmacodynamics (A, C) is the study of the biochemical and physiological effects of
drugs on the body .
2. What is the primary focus of pharmacodynamics?
A) Drug absorption and distribution
B) The biochemical and physiological effects of drugs on the body
C) Drug metabolism and excretion
D) Drug dosage calculations
Correct Answer: B
Rationale: Pharmacodynamics is the study of how medications interact with receptors to
produce a biological response. Pharmacokinetics (A, C) covers ADME processes .
3. The "first-pass effect" refers to:
A) Drug distribution into body tissues
B) Drug metabolism in the liver before reaching systemic circulation
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
,Correct Answer: B
Rationale: First-pass metabolism reduces the amount of active drug reaching systemic
circulation after oral administration, directly impacting bioavailability. This occurs primarily in
the liver .
4. Which route of administration would most effectively bypass first-pass metabolism?
A) Oral
B) Sublingual
C) Intravenous
D) Subcutaneous
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream,
completely bypassing first-pass metabolism. Sublingual and subcutaneous routes also bypass
first-pass to some extent, but IV provides 100% bioavailability .
5. A patient with liver disease is prescribed a medication primarily metabolized by the liver.
The NP anticipates which change in drug levels?
A) Decreased drug levels
B) Increased drug levels
C) No change in drug levels
D) Unpredictable drug levels
Correct Answer: B
Rationale: Liver disease reduces the organ's metabolic capacity, leading to decreased clearance
and increased drug levels. Dosage adjustments are typically required .
6. What is the primary organ responsible for drug excretion?
A) Liver
B) Kidneys
C) Lungs
D) Skin
Correct Answer: B
Rationale: The kidneys are the primary organ for drug excretion. Impaired renal function
requires dosage adjustments to prevent drug accumulation and toxicity .
,7. A patient with renal impairment is prescribed a drug excreted primarily by the kidneys. The
NP should:
A) Prescribe a higher dose
B) Prescribe a lower dose
C) Prescribe the standard dose
D) Avoid prescribing the drug
Correct Answer: B
Rationale: Impaired renal function decreases drug excretion, leading to accumulation. Lower
doses or extended dosing intervals are required to prevent toxicity .
8. What is the effect of a high-fat meal on drug absorption?
A) Always increases absorption
B) Always decreases absorption
C) Can increase or decrease absorption depending on the drug
D) Has no effect on absorption
Correct Answer: C
Rationale: High-fat meals can increase absorption of lipophilic drugs but may delay or decrease
absorption of other drugs. Specific drug-food interactions vary .
9. Which of the following factors decreases drug absorption from the gastrointestinal tract?
A) Increased blood flow to the GI tract
B) Presence of food that binds the drug
C) Decreased gastric pH for acid-stable drugs
D) Large surface area of the small intestine
Correct Answer: B
Rationale: Food that binds drugs (e.g., calcium in dairy binding tetracycline) decreases
absorption. Increased blood flow, decreased gastric pH for acid-stable drugs, and large surface
area increase absorption .
10. The NP understands that a drug's volume of distribution (Vd) is affected by:
A) Protein binding
B) Tissue perfusion
, C) Lipid solubility
D) All of the above
Correct Answer: D
Rationale: Volume of distribution is affected by protein binding (bound drugs stay in plasma),
tissue perfusion (well-perfused organs receive more drug), and lipid solubility (lipophilic drugs
distribute into tissues) .
11. A patient is receiving a drug that is highly protein-bound (98%). Another highly protein-
bound drug is added. The NP should monitor for:
A) Decreased effectiveness of the first drug
B) Increased risk of toxicity of the first drug
C) No change in drug levels
D) Faster elimination of both drugs
Correct Answer: B
Rationale: Competition for protein-binding sites can displace the first drug, increasing free
(active) drug levels and risk of toxicity .
12. Which of the following describes a drug agonist?
A) Binds to a receptor and blocks a response
B) Binds to a receptor and produces a response
C) Has no effect on receptors
D) Enhances metabolism
Correct Answer: B
Rationale: An agonist binds to a receptor and activates it, producing a response. An antagonist
(A) binds but blocks the response .
13. A patient develops a rash after starting a new antibiotic. This is classified as:
A) Therapeutic effect
B) Adverse drug reaction
C) Drug tolerance
D) Placebo effect
Fundamentals Midterm Exam Newest 2026 Actual
Questions and Correct Answers (Latest
Update) Graded A+ 100% Guarantee Verified by
Experts - Chamberlain
1. Which of the following best defines pharmacokinetics?
A) The effect of the drug on the body
B) The movement of the drug through the body
C) The interaction between drugs and receptors
D) The therapeutic effect produced by the drug
Correct Answer: B
Rationale: Pharmacokinetics describes the movement of a drug through the body over time,
specifically focusing on the four stages: absorption, distribution, metabolism, and excretion
(ADME). Pharmacodynamics (A, C) is the study of the biochemical and physiological effects of
drugs on the body .
2. What is the primary focus of pharmacodynamics?
A) Drug absorption and distribution
B) The biochemical and physiological effects of drugs on the body
C) Drug metabolism and excretion
D) Drug dosage calculations
Correct Answer: B
Rationale: Pharmacodynamics is the study of how medications interact with receptors to
produce a biological response. Pharmacokinetics (A, C) covers ADME processes .
3. The "first-pass effect" refers to:
A) Drug distribution into body tissues
B) Drug metabolism in the liver before reaching systemic circulation
C) Drug excretion by the kidneys
D) Drug binding to plasma proteins
,Correct Answer: B
Rationale: First-pass metabolism reduces the amount of active drug reaching systemic
circulation after oral administration, directly impacting bioavailability. This occurs primarily in
the liver .
4. Which route of administration would most effectively bypass first-pass metabolism?
A) Oral
B) Sublingual
C) Intravenous
D) Subcutaneous
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream,
completely bypassing first-pass metabolism. Sublingual and subcutaneous routes also bypass
first-pass to some extent, but IV provides 100% bioavailability .
5. A patient with liver disease is prescribed a medication primarily metabolized by the liver.
The NP anticipates which change in drug levels?
A) Decreased drug levels
B) Increased drug levels
C) No change in drug levels
D) Unpredictable drug levels
Correct Answer: B
Rationale: Liver disease reduces the organ's metabolic capacity, leading to decreased clearance
and increased drug levels. Dosage adjustments are typically required .
6. What is the primary organ responsible for drug excretion?
A) Liver
B) Kidneys
C) Lungs
D) Skin
Correct Answer: B
Rationale: The kidneys are the primary organ for drug excretion. Impaired renal function
requires dosage adjustments to prevent drug accumulation and toxicity .
,7. A patient with renal impairment is prescribed a drug excreted primarily by the kidneys. The
NP should:
A) Prescribe a higher dose
B) Prescribe a lower dose
C) Prescribe the standard dose
D) Avoid prescribing the drug
Correct Answer: B
Rationale: Impaired renal function decreases drug excretion, leading to accumulation. Lower
doses or extended dosing intervals are required to prevent toxicity .
8. What is the effect of a high-fat meal on drug absorption?
A) Always increases absorption
B) Always decreases absorption
C) Can increase or decrease absorption depending on the drug
D) Has no effect on absorption
Correct Answer: C
Rationale: High-fat meals can increase absorption of lipophilic drugs but may delay or decrease
absorption of other drugs. Specific drug-food interactions vary .
9. Which of the following factors decreases drug absorption from the gastrointestinal tract?
A) Increased blood flow to the GI tract
B) Presence of food that binds the drug
C) Decreased gastric pH for acid-stable drugs
D) Large surface area of the small intestine
Correct Answer: B
Rationale: Food that binds drugs (e.g., calcium in dairy binding tetracycline) decreases
absorption. Increased blood flow, decreased gastric pH for acid-stable drugs, and large surface
area increase absorption .
10. The NP understands that a drug's volume of distribution (Vd) is affected by:
A) Protein binding
B) Tissue perfusion
, C) Lipid solubility
D) All of the above
Correct Answer: D
Rationale: Volume of distribution is affected by protein binding (bound drugs stay in plasma),
tissue perfusion (well-perfused organs receive more drug), and lipid solubility (lipophilic drugs
distribute into tissues) .
11. A patient is receiving a drug that is highly protein-bound (98%). Another highly protein-
bound drug is added. The NP should monitor for:
A) Decreased effectiveness of the first drug
B) Increased risk of toxicity of the first drug
C) No change in drug levels
D) Faster elimination of both drugs
Correct Answer: B
Rationale: Competition for protein-binding sites can displace the first drug, increasing free
(active) drug levels and risk of toxicity .
12. Which of the following describes a drug agonist?
A) Binds to a receptor and blocks a response
B) Binds to a receptor and produces a response
C) Has no effect on receptors
D) Enhances metabolism
Correct Answer: B
Rationale: An agonist binds to a receptor and activates it, producing a response. An antagonist
(A) binds but blocks the response .
13. A patient develops a rash after starting a new antibiotic. This is classified as:
A) Therapeutic effect
B) Adverse drug reaction
C) Drug tolerance
D) Placebo effect
